ERβ activation improves nonylphenol-induced depression and neurotransmitter secretion disruption via the TPH2/5-HT

Jie Yu1, Yujie Zhang1, Hao Yao1

  • 1School of Public Health, Zunyi Medical University, Zunyi, Guizhou 563000, PR China.

Insights

Estrogen receptor beta (ERβ) plays a crucial role in mitigating nonylphenol (NP)-induced depression-like behaviors in rats. ERβ activation helps restore neurotransmitter balance and alleviate behavioral changes associated with NP exposure.

Area of Science:

  • Neuroendocrinology
  • Environmental Toxicology
  • Behavioral Neuroscience

Background:

  • Nonylphenol (NP) is an environmental endocrine disruptor linked to adverse health effects.
  • Estrogen receptor beta (ERβ) is implicated in regulating mood and neurochemical pathways.
  • The TPH2/5-HT pathway is critical for serotonin synthesis and mood regulation.

Purpose of the Study:

  • To investigate the role of ERβ in nonylphenol (NP)-induced depression-like behavior in rats.
  • To examine the impact of ERβ on the TPH2/5-HT pathway regulation.
  • To assess the therapeutic potential of ERβ agonists in mitigating NP toxicity.

Main Methods:

  • In vitro studies using RBL-2H3 cells exposed to NP and/or an ERβ agonist.
  • In vivo studies involving Sprague-Dawley rats treated with NP, ERβ agonist (DPN), or ERβ inhibitor (PHTPP).
  • Behavioral tests (e.g., feeding latency, immobility time) and molecular analyses (gene/protein expression, neurotransmitter levels).

Main Results:

  • NP exposure decreased ERβ, TPH1, TPH2 expression, and neurotransmitter levels (DA, NE, 5-HT) in vitro and in vivo.
  • NP induced depression-like behaviors in rats, including increased feeding latency, reduced food intake, and prolonged immobility.
  • ERβ agonist administration alleviated NP-induced behavioral and molecular alterations, activating the TPH2/5-HT pathway.

Conclusions:

  • Estrogen receptor beta (ERβ) is a key mediator in nonylphenol-induced depression-like behaviors.
  • ERβ activation ameliorates NP-induced neurochemical imbalances and behavioral deficits via the TPH2/5-HT pathway.
  • Targeting ERβ may offer a therapeutic strategy against environmental toxin-induced mood disorders.